MediPoint: Enteral Stents - North America Forecast and Market Analysis
Enteral stents market is a leading non-vascular stents market. This market includes esophageal stents, gastro duodenal stents, and colonic stents, and is divided into three segments: fully covered enteral stents, partially covered enteral stents, and non-covered enteral stents. As a whole, the enteral stents market is increasing, primarily due to globally rising cancer rates, specifically esophageal, stomach, pancreatic, and colorectal cancers, and by an increased awareness of stenting as a palliative treatment.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
North American market for enteral stents, which encompasses three countries and includes esophageal stents, gastrointestinal stents, and colonic stents, was valued at approximately $46.8M in 2016. The market is expected to grow at a CAGR of 4.2%, to reach a valuation of $62.3M in 2023.
The key drivers of this market during the forecast period are -
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook